Selective serotonin reuptake inhibitors vs tricyclic antidepressants (TCAs)
Acceptability ‐ total dropouts · patients with cancer and depression
It is very uncertain whether selective serotonin reuptake inhibitors (SSRIs) changes dropouts due to any cause (acceptability) compared with tricyclic antidepressants (TCAs) (very low certainty).
1 finding from 1 review
- Antidepressants for the treatment of depression in people with cancer 2023 · Cochrane Headline outcomes onlyRR 0.83 [0.53, 1.3]3 studies · 237 participantsVery low